Adipotide

Research protocols established 0.43 mg/kg daily subcutaneous injection as the optimal efficacious dose based on primate studies, administered for 28-day treatment cycles followed by mandatory 28-56 day recovery periods. For a 70kg human, this translates to approximately 30mg daily. Alternative investigational schedules suggest 0.3-0.5 mg/kg for weeks 1-2 to assess tolerance, escalating to 0.43 mg/kg for weeks 3-4 if kidney function remains stable. Injection sites must be rotated daily between abdomen, thigh, and upper arm to prevent lipodystrophy. Critical monitoring includes twice-weekly serum creatinine, BUN, urinalysis, and comprehensive metabolic panels due to nephrotoxicity risk. Treatment should be discontinued immediately if creatinine rises >50% above baseline.

Since Adipotide was never approved for humans, dosing is based entirely on animal research. The standard monkey dose was about 0.4mg per kilogram of body weight daily - so a 150-pound person would theoretically use about 30mg per day. You inject it under the skin once daily for exactly 28 days, then take at least 28 days completely off to let your kidneys recover. You must change injection spots every day to avoid skin problems. Because of serious kidney risks, you'd need blood tests twice a week to check kidney function, and stop immediately if your kidney numbers get worse. This isn't like other peptides where you can adjust doses - the kidney toxicity makes it an all-or-nothing proposition.

Subcutaneous injection using insulin syringes or pen devices, administered once daily at consistent timing. Reconstitute lyophilized powder with bacteriostatic water to achieve appropriate concentration based on body weight calculations. Inject into subcutaneous tissue at 45-90 degree angle using proper sterile technique. Mandatory site rotation between abdomen (avoiding 2-inch radius around navel), anterior thigh, and posterior upper arm to prevent injection site complications. Administer at same time daily, preferably morning to monitor for acute adverse reactions during active hours. Unlike other peptides, Adipotide requires strict adherence to 28-day treatment windows with mandatory recovery periods. Concurrent hydration monitoring and nephrotoxicity assessment through regular laboratory evaluation is essential and non-optional.

Subcutaneous injection using insulin syringes or pen devices, administered once daily at consistent timing. Reconstitute lyophilized powder with bacteriostatic water to achieve appropriate concentration based on body weight calculations. Inject into subcutaneous tissue at 45-90 degree angle using proper sterile technique. Mandatory site rotation between abdomen (avoiding 2-inch radius around navel), anterior thigh, and posterior upper arm to prevent injection site complications. Administer at same time daily, preferably morning to monitor for acute adverse reactions during active hours. Unlike other peptides, Adipotide requires strict adherence to 28-day treatment windows with mandatory recovery periods. Concurrent hydration monitoring and nephrotoxicity assessment through regular laboratory evaluation is essential and non-optional.

Injection Protocol

• •Subcutaneous injection DAILY for 28 days
• •MANDATORY daily site rotation (abdomen, thigh, arm)
• •Same time DAILY (preferably morning for monitoring)
• •CRITICAL: Take with adequate hydration

Monitoring Schedule

• •CRITICAL: Twice-weekly serum creatinine & BUN
• •CRITICAL: Twice-weekly urinalysis for protein
• •CRITICAL: Weekly comprehensive metabolic panel
• •STOP IMMEDIATELY if creatinine >50% above baseline